RXFP1 Antikörper (Extracellular Domain, N-Term)
-
- Target Alle RXFP1 Antikörper anzeigen
- RXFP1 (Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1))
-
Bindungsspezifität
- Extracellular Domain, N-Term
-
Reaktivität
- Human, Schwein
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser RXFP1 Antikörper ist unkonjugiert
-
Applikation
- Immunohistochemistry (Paraffin-embedded Sections) (IHC (p))
- Spezifität
- Reacts with the N-terminus part of human and pig RXFP1
- Kreuzreaktivität
- Rind (Kuh)
- Kreuzreaktivität (Details)
- BLAST analysis of the peptide immunogen showed no homology with other human proteins, except GPR22 (58 % ). Predicted to cross react with monkey, rat, bovine, dog and horse.
- Aufreinigung
- Antigen affinity purified
- Immunogen
- Synthetic 19 amino acid peptide from N-terminal extracellular domain of human RXFP1. Percent identity with other species by BLAST analysis: Human, Gorilla, Gibbon, Marmoset, Panda, Pig (100%), Orangutan (95%)
- Isotyp
- IgG
- Top Product
- Discover our top product RXFP1 Primärantikörper
-
-
- Applikationshinweise
-
Working dilution: Optimal dilutions should be determined by the end user.
The following are guidelines only:
IHC-P (40 μg/mL) - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 1 mg/mL
- Buffer
- PBS, Sodium azide 0.1 %
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C/-80 °C
- Informationen zur Lagerung
- Long term: -70°C, Short term: +4°C
-
- Target
- RXFP1 (Relaxin/insulin-Like Family Peptide Receptor 1 (RXFP1))
- Andere Bezeichnung
- RXFP1 (RXFP1 Produkte)
- Synonyme
- LGR7 antikoerper, RXFPR1 antikoerper, Gm1018 antikoerper, Lgr7 antikoerper, RXFP2 antikoerper, relaxin/insulin like family peptide receptor 1 antikoerper, relaxin/insulin-like family peptide receptor 1 antikoerper, RXFP1 antikoerper, rxfp1 antikoerper, Rxfp1 antikoerper
- Gen-ID
- 59350
- Pathways
- Myometrial Relaxation and Contraction
-